Attached files

file filename
8-K - FORM 8-K - PATTERSON COMPANIES, INC.d8k.htm

Exhibit 99.1

Patterson Companies Reports 6% Comparable Revenue Growth in First Quarter

$0.45 EPS on Comparable Basis

St. Paul, MN—August 25, 2011— Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated sales of $847,422,000 for the first quarter of fiscal 2012 ended July 30, an increase of approximately 6% on a comparable basis from the year-earlier period. Comparable basis sales exclude the impact of an extra week in the first quarter of fiscal 2011. Reported sales in last year’s first quarter totaled $849,787,000.

Patterson reported first quarter net income of $48,610,000 or $0.42 per diluted share, which included previously-announced non-cash expense of $0.03 per diluted share related to Patterson’s Employee Stock Ownership Plan (ESOP). After adjusting for this ESOP-related expense, first quarter earnings were $0.45 per diluted share. Patterson reported earnings of $53,925,000 or $0.45 per diluted share in the first quarter of fiscal 2011. As reported in Patterson’s earnings release for the fourth quarter of fiscal 2011, the non-cash ESOP expense will affect the ongoing comparability of results for fiscal year 2012 earnings and beyond when compared to periods ended before fiscal 2012. The total impact in fiscal 2012 is estimated at $0.12 per share. A reconciliation of the impact on net earnings and per share amounts from this change is included at the end of this release.

In other developments, Webster Veterinary, Patterson’s companion-pet veterinary business, today announced the acquisition of American Veterinary Supply Corporation (AVSC), a full-service veterinary distributor on Long Island that serves approximately 2,000 veterinary practices and hospitals in the New York metropolitan area. With sales of approximately $25 million and 14 field sales representatives, AVSC will be operated as Webster’s eighteenth branch. Terms of the transaction were not disclosed.

Patterson Dental, Patterson’s largest business, reported comparable basis sales growth of approximately 4% to $533,367,000 in the first quarter.

 

   

Sales of consumable dental supplies and printed office products increased an estimated 2% on a comparable basis in the first quarter.

 

   

Sales of dental equipment and software increased an estimated 7% on a comparable basis from the year-earlier level, paced by strong, double-digit sales growth of new-technology equipment, including CEREC® and digital radiography products.

 

   

Sales of other services and products, consisting primarily of technical service, parts and labor, software support services and artificial teeth, increased an estimated 6% on a comparable basis from last year’s first quarter.

First quarter sales of Patterson Medical, the rehabilitation supply and equipment unit, rose approximately 12% on a comparable basis to $134,452,000. Internally-generated sales increased approximately 1% on a comparable basis, while the June 2010 acquisitions of the healthcare businesses of DCC Healthcare and favorable foreign currency adjustments accounted for the balance of the year-over-year sales growth. Sales of the Webster Veterinary unit increased approximately 8% on a comparable basis from the year-earlier period to $179,603,000.

Scott P. Anderson, president and chief executive officer, commented: “Within Patterson Dental, sales of consumable supplies grew modestly on a comparable basis, as the market continues to be affected by a sluggish economy. Our dental equipment growth was driven by strong sales of our various new-technology equipment lines as dentists are continuing to invest in the digital conversion that is transforming the practice of dentistry. Patterson Dental is the leading distributor of new-technology equipment by a significant margin, and we see ongoing growth opportunities in this key area.”


He continued: “We believe Patterson Medical continued to gain market share in the first quarter despite market and changing regulatory conditions in North America and overseas. The integration of the DCC businesses has been completed, and no significant incremental expenses related to this transaction are anticipated going forward. We continue to believe Patterson Medical is well positioned, domestically and internationally, as an ongoing growth driver of our overall performance.”

Anderson added: “Webster’s first quarter sales growth on a comparable basis, which was driven by improved sales of both consumable supplies and equipment and software, was largely consistent with our internal forecast. We plan to continue investing in the unit’s relatively new equipment and service business, which has expanded Webster’s full-service platform. Webster also is investing in a range of technology initiatives aimed at strengthening the profitability of veterinary practices and forging stronger relationships between pet owners and their veterinarians. We believe these initiatives should further strengthen Webster’s competitive position in coming years.”

Patterson has used internally-generated cash to repurchase $157 million or 4.9 million shares of its common stock since its new 25 million share, five-year buyback was authorized in March 2011. This included the repurchase of nearly 2 million shares in the most recent quarter.

Patterson reiterated its previously announced financial guidance of $1.90 to $2.00 per diluted share for fiscal 2012.

ESOP Expense Reconciliation Table

Dollars in thousands, except EPS

 

     July 30, 2011      July 31, 2010  

Net Income

   $ 48,610       $ 53,925   

Incremental ESOP Expense

     3,219         —     
  

 

 

    

 

 

 

Adjusted Net Income (non-GAAP)

   $ 51,829       $ 53,925   
  

 

 

    

 

 

 

Diluted Earnings Per Share

   $ 0.42       $ 0.45   

Incremental ESOP Expense

   $ 0.03         —     
  

 

 

    

 

 

 

Adjusted Earnings Per Share (non-GAAP)

   $ 0.45       $ 0.45   
  

 

 

    

 

 

 

About Patterson Companies, Inc.

Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets.

Dental Market

As Patterson’s largest business, Patterson Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.

Veterinary Market

Webster Veterinary is the nation’s second largest distributor of consumable veterinary supplies, equipment and software, diagnostic products, vaccines and pharmaceuticals to companion-pet veterinary clinics.

Rehabilitation Market

Patterson Medical is the world’s leading distributor of rehabilitation supplies and non-wheelchair assistive patient products to the physical and occupational therapy markets. The unit’s global customer base includes hospitals, long-term care facilities, clinics and dealers.

#            #             #


This release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond the Company’s ability to control. The Company cautions shareholders and prospective investors that the following factors, among others, may cause actual results to differ materially from those indicated by the forward-looking statements: competition within the dental, veterinary, and rehabilitative and assistive living supply industries; changes in the economics of dentistry, including reduced growth in expenditures by private dental insurance plans, the effects of economic conditions and the effects of healthcare reform, which may affect future per capita expenditures for dental services and the ability and willingness of dentists to invest in high-technology products; the effects of healthcare related legislation and regulation which may affect expenditures or reimbursements for rehabilitative and assistive products; changes in the economics of the veterinary supply market, including reduced growth in per capita expenditures for veterinary services and reduced growth in the number of households owning pets; the ability of the Company to maintain satisfactory relationships with its sales force; unexpected loss of key senior management personnel; unforeseen operating risks; risks associated with the dependence on manufacturers of the Company’s products; and the ability of the Company to successfully integrate the recent acquisitions into its existing business. Forward-looking statements are qualified in their entirety by the cautionary language set forth in the Company’s filings with the Securities and Exchange Commission.

 

For additional information contact:   
R. Stephen Armstrong    Richard G. Cinquina
Executive Vice President & CFO    Equity Market Partners
651/686-1600    904/415-1415

 

 

First Quarter Conference Call and Replay

Patterson’s first quarter earnings conference call will start at 10:00 a.m. Eastern today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com. The conference call will be archived on Patterson’s web site. A replay of the first quarter conference call can be heard for one month at 1-303-590-3030 and providing the conference ID: 4465229.


PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except for per share amounts)

(Unaudited)

 

     Three Months Ended  
     July 30,
2011
    July 31,
2010
 

Net sales

   $ 847,422      $ 849,787   

Gross profit

     278,276        280,200   

Operating expenses

     196,283        191,176   
  

 

 

   

 

 

 

Operating income

     81,993        89,024   

Other expense, net

     (5,135     (3,257
  

 

 

   

 

 

 

Income before taxes

     76,858        85,767   

Income taxes

     28,248        31,842   
  

 

 

   

 

 

 

Net income

   $ 48,610      $ 53,925   
  

 

 

   

 

 

 

Earnings per share:

    

Basic

   $ 0.42      $ 0.45   

Diluted

   $ 0.42      $ 0.45   

Shares:

    

Basic

     115,576        119,022   

Diluted

     116,285        119,784   

Dividends declared per common share

   $ 0.12      $ 0.10   

Gross margin

     32.8     33.0

Operating expenses as a % of net sales

     23.2     22.5

Operating income as a % of net sales

     9.7     10.5

Effective tax rate

     36.8     37.1

 

-more-


PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

 

      July 30,
2011
     April 30,
2011
 
     (Unaudited)         

ASSETS

     

Current assets:

     

Cash and short-term investments

   $ 373,776       $ 388,665   

Receivables, net

     423,285         465,170   

Inventory

     346,476         336,094   

Prepaid expenses and other current assets

     35,195         40,780   
  

 

 

    

 

 

 

Total current assets

     1,178,732         1,230,709   

Property and equipment, net

     196,243         189,583   

Goodwill and other intangible assets

     1,018,983         1,022,832   

Investments and other

     123,555         121,844   
  

 

 

    

 

 

 

Total Assets

   $ 2,517,513       $ 2,564,968   
  

 

 

    

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

     

Current liabilities:

     

Accounts payable

   $ 201,801       $ 210,033   

Other accrued liabilities

     147,909         157,398   

Current maturities of long-term debt

     —           —     
  

 

 

    

 

 

 

Total current liabilities

     349,710         367,431   

Long-term debt

     525,000         525,000   

Other non-current liabilities

     108,652         111,997   
  

 

 

    

 

 

 

Total liabilities

     983,362         1,004,428   

Stockholders’ equity

     1,534,151         1,560,540   
  

 

 

    

 

 

 

Total Liabilities and Stockholders’ Equity

   $ 2,517,513       $ 2,564,968   
  

 

 

    

 

 

 

 

-more-


PATTERSON COMPANIES, INC.

SUPPLEMENTARY FINANCIAL DATA

(Dollars in thousands)

(Unaudited)

 

     Three Months Ended  
     July 30,
2011
    July 31,
2010
 

Consolidated Net Sales

    

Consumable and printed products

   $ 574,962      $ 586,603   

Equipment and software

     199,651        192,221   

Other

     72,809        70,963   
  

 

 

   

 

 

 

Total

   $ 847,422      $ 849,787   
  

 

 

   

 

 

 

Dental Supply

    

Consumable and printed products

   $ 308,869      $ 325,992   

Equipment and software

     161,027        154,571   

Other

     63,471        62,115   
  

 

 

   

 

 

 

Total

   $ 533,367      $ 542,678   
  

 

 

   

 

 

 

Rehabilitation Supply

    

Consumable and printed products

   $ 96,716      $ 90,925   

Equipment and software

     31,057        30,376   

Other

     6,679        6,173   
  

 

 

   

 

 

 

Total

   $ 134,452      $ 127,474   
  

 

 

   

 

 

 

Veterinary Supply

    

Consumable and printed products

   $ 169,377      $ 169,686   

Equipment and software

     7,567        7,274   

Other

     2,659        2,675   
  

 

 

   

 

 

 

Total

   $ 179,603      $ 179,635   
  

 

 

   

 

 

 

Other (Expense) Income, net

    

Interest income

   $ 1,829      $ 2,643   

Interest expense

     (6,353     (6,890

Other

     (611     990   
  

 

 

   

 

 

 
   $ (5,135   $ (3,257
  

 

 

   

 

 

 

 

-more-


PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

 

     Three Months Ended  
     July 30,
2011
    July 31,
2010
 

Operating activities:

    

Net income

   $ 48,610      $ 53,925   

Depreciation & amortization

     9,082        9,523   

Stock-based compensation

     3,180        2,669   

ESOP compensation

     5,700        525   

Change in assets and liabilities, net of acquired

     144        (43,884
  

 

 

   

 

 

 

Net cash provided by operating activities

     66,716        22,758   

Investing activities:

    

Additions to property and equipment, net of disposals

     (10,247     (9,130

Acquisitions and equity investments

     —          (46,682
  

 

 

   

 

 

 

Net cash used in investing activities

     (10,247     (55,812

Financing activities:

    

Dividends paid

     (13,801     (11,916

Share repurchases

     (59,913     —     

Other financing activities

     4,199        7,988   
  

 

 

   

 

 

 

Net cash used in financing activities

     (69,515     (3,928

Effect of exchange rate changes on cash

     (1,843     (5,182
  

 

 

   

 

 

 

Net decrease in cash and cash equivalents

   $ (14,889   $ (42,164